Alnylam Pharma (ALNY) Confirms Approval of GIVLAARI by FDA
Go back to Alnylam Pharma (ALNY) Confirms Approval of GIVLAARI by FDA| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 249.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.59 | 52 Week High | $109.10 | |||
| Open | $249.59 | 52 Week Low | $31.38 | |||
| Day High | $249.59 | P/E | N/A | |||
| Day Low | $249.59 | EPS | $-1.45 | |||
| Volume | 42 | |||||
